Testing effectiveness (Phase 2)Ended earlyNCT04037891
What this trial is testing
Topical rVA576 for Treatment of Atopic Keratoconjunctivitis
Who this might be right for
Keratoconjunctivitis, AtopicKeratoconjunctivitis, VernalConjunctivitis, Allergic
AKARI Therapeutics 12